🔎 Trials Near Me

Akèy › Maladi poumon entèstisyèl › Alabama › Birmingham

Etid klinik pou Maladi poumon entèstisyèl nan Birmingham, AL

9 etid pou Maladi poumon entèstisyèl ap chèche patisipan nan sit nan ak bò kote Birmingham (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

Ap rekriteFaz 3
  • University of Alabama at Birmingham, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07540988

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Ap rekriteFaz 2
  • University of Alabama, Birmingham
Laj 18 a 80 · Tout sèks · Mizajou Sep 29, 2026 · NCT05798923

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

Ap rekriteFaz 2
  • UAB Lung Health Center, Birmingham
Laj 40 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06968845

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

Ap rekrite
  • University of Alabama at Birmingham, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06911632

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Ap rekriteEtid obsèvasyon
  • University of Alabama at Birmingham, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06388421

Platform Clinical Study for Conquering Scleroderma

Ap rekriteFaz 2
  • University of Alabama - Division of Pulmonary and Critical Care Medicine, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT06195072

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

Ap rekriteEtid obsèvasyon
  • University of Alabama - Birmingham, Birmingham
Laj 21 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT01915511

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Ap rekriteFaz 3
  • UAB Lung Health Center, Birmingham
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT05943535

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

Ap rekriteFaz 2
  • University of Alabama at Birmingham, Birmingham
Laj 40 ak plis · Tout sèks · Mizajou Nov 12, 2025 · NCT05975983

Etid Maladi poumon entèstisyèl nan lòt vil

Lòt etid nan Birmingham

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.